TTF-1 positive posterior pituitary tumor: Limitations of current treatment and potential new hope in BRAF V600E mutation variants

Fakhry M. Dawoud, Ryan M. Naylor, Caterina Giannini, Amy A. Swanson, Fredric B. Meyer, Joon H. Uhm

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Article number106059
JournalClinical Neurology and Neurosurgery
Volume196
DOIs
StatePublished - Sep 2020

Keywords

  • BRAF V600E mutation
  • Dabrafenib
  • MAPK/ERK
  • Panniculitis
  • Papillary TTF-1 positive posterior pituitary tumor
  • Pituitary spindle cell oncocytoma
  • Trametinib

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this